Score contribution per author:
α: calibrated so average coauthorship-adjusted count equals average raw count
Using comprehensive U.S. drug claims data, we show that adherence to asthma control medication declined during the COVID‐19 pandemic. We find that young children exhibited a 40 percent decrease in adherence by the end of 2020. The responses were less negative for older children and positive for adults. We provide additional evidence that parental attention played a role in driving this decrease, based on heterogeneity by pre‐pandemic mail order usage and number of parental scripts. Policy implications for improving pediatric adherence are discussed.